Live feed19:00:31·218dINSIDERFilingvia QuantisnowChief Commercial Officer Merendino Lauren converted options into 10,536 shares and sold $33,216 worth of shares (3,726 units at $8.91), increasing direct ownership by 15% to 50,809 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.DAWN· Day One Biopharmaceuticals Inc.Health CareOriginal source